A Study to Assess the Skin Irritation and Sensitization of Selegiline TDS in Healthy Subjects

Clinical trial NCT07452692 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07452692
Sponsor: Corium Innovations, Inc.
Status: NOT_YET_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Major Depressive Disorder (MDD)

Start date: 2026-07-01
Primary completion: 2026-10-07
Enrollment: 230

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.